Veterinary Stereotactic Radiosurgery System Market Report 2026

Veterinary Stereotactic Radiosurgery System Market Overview

• Veterinary Stereotactic Radiosurgery System market size has reached to $3.28 billion in 2025 • Expected to grow to $5.9 billion in 2030 at a compound annual growth rate (CAGR) of 12.5% • Growth Driver: Pet Population Surge Boosts Growth In The Veterinary Stereotactic Radiosurgery System Market • Market Trend: AI-Enabled Precision Treatment Delivery Transforming Veterinary Stereotactic Radiosurgery System • North America was the largest region in 2025.

What Is Covered Under Veterinary Stereotactic Radiosurgery System Market?

A veterinary stereotactic radiosurgery system refers to a form of external radiation therapy that positions the patient precisely while administering a single, high dosage of radiation to a tumor. The main types of veterinary stereotactic radiosurgery systems are microsurgical instrumentation, optical or viewing instruments, and other products. Microsurgical instrumentation refers to surgical tools that are held in the hand and are made especially for microsurgical and delicate procedures, holding fragile tissues, tendons, and blood vessels. The various modalities involved are gamma knife, linear accelerator, particle beam radiation therapy, and cyber knife that are used for canine, feline, and other applications. The different end users include hospitals, contract research organizations (CROs), and others.

What Is The Veterinary Stereotactic Radiosurgery System Market Growth Forecast?

The veterinary stereotactic radiosurgery system market size is expected to see rapid growth in the next few years. It will grow to $5.9 billion in 2030 at a compound annual growth rate (CAGR) of 12.5%. The growth in the forecast period can be attributed to development of high-precision radiation delivery systems, integration of AI in treatment planning, growth in canine and feline oncology programs, increasing investments in veterinary cancer care, expansion of contract research organizations (CROs) supporting animal oncology. Major trends in the forecast period include increasing adoption of stereotactic radiosurgery in veterinary oncology, development of minimally invasive treatment options, integration of advanced imaging for precise tumor targeting, expansion of specialized veterinary cancer centers, rising awareness of pet cancer treatment options.

What Is The Driver Of The Veterinary Stereotactic Radiosurgery System Market?

The rise in the pet population is expected to propel the growth of the veterinary stereotactic radiosurgery system market going forward. Pet population refers to the total number of domesticated animals, such as dogs, cats, and other pets, that are kept and cared for by people within a specific area or community. Pet population is rising because more households are adopting animals for companionship, leading to an increase in the number of pets cared for in communities. Veterinary stereotactic radiosurgery systems help the pet population by providing precise, non-invasive treatment for tumors and other serious conditions, improving recovery outcomes and quality of life. For instance, in July 2025, according to the World Animal Foundation (WAF), a US-based organizations focused on animal welfare, pet ownership is now at 71% of U.S. households, up from 66% in 2023–2024. Therefore, the rise in the pet population is driving the growth of the veterinary stereotactic radiosurgery system industry.

Key Players In The Global Veterinary Stereotactic Radiosurgery System Market

Major companies operating in the veterinary stereotactic radiosurgery system market are PetCure Oncology, Elekta AB, Accuray Incorporated, Varian Medical Systems Inc., ZAP Surgical Systems Inc., Brainlab AG, Best Medical International Inc., Mevion Medical Systems Inc., Vision RT Limited, ViewRay Inc., Xstrahl Ltd., Avante Health Solutions, Medtronic plc, RaySearch Laboratories, Best Theratronics Ltd., MASEP Medical Science Technology Development Co Ltd, RefleXion Medical Inc., CIVCO Radiotherapy, Xcision Medical Systems, GammaVet, RadVet, ALCEN, Isoray Inc., PTW Freiburg GmbH, Ion Beam Applications SA, Nanovi Radiotherapy AS

Global Veterinary Stereotactic Radiosurgery System Market Trends and Insights

Major companies operating in the veterinary stereotactic radiosurgery system market are focusing on technological advancements, such as AI-driven image-guided treatment delivery platforms, to gain a competitive advantage. AI-driven image-guided treatment delivery platforms are integrated digital systems that combine artificial intelligence with imaging and robotic controls to plan, prescribe, and precisely deliver stereotactic radiation therapies within a prescription delivery service framework, improving treatment accuracy, reducing procedure times, and enhancing clinical workflow efficiency. For instance, in September 2024, Bluepearl Veterinary Partners LLC, a US-based veterinary care provider, introduced the CyberKnife System for veterinary use, featuring a robotic linear accelerator capable of delivering high-energy photon beams from numerous angles, real-time imaging guidance to minimize healthy tissue exposure, and sub-millimeter targeting precision for complex tumors. This deployment expands access to advanced oncology care for animals and strengthens specialty clinical capabilities but requires significant investment in training and infrastructure.

What Are Latest Mergers And Acquisitions In The Veterinary Stereotactic Radiosurgery System Market?

In November 2025, Empyrean Medical Systems Inc, a US-based medical technology company, partnered with Pathway Vet Alliance LLC to deploy its Sirius advanced radiation platform and expand access to precision stereotactic radiation therapy for pets. With this collaboration, Empyrean aimed to bring its Sirius advanced radiation platform into the veterinary oncology market to expand access to human grade precision stereotactic radiation therapy for pets battling cancer. Pathway Vet Alliance LLC is a US-based veterinary services community that provides access to the Veterinary Stereotactic Radiosurgery (SRS) system

What Defines the Veterinary Stereotactic Radiosurgery System Market?

A veterinary stereotactic radiosurgery system market includes revenues earned by entities by veterinary stereotactic radiosurgery system that are used in the treatment of cancers and other issues that affect the brain, neck, lungs, liver, spine, and other areas of the body of pets and animals. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Veterinary Stereotactic Radiosurgery System Market Report 2026?

The veterinary stereotactic radiosurgery system market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the veterinary stereotactic radiosurgery system industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.